XML 57 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Jun. 30, 2013
Jul. 01, 2012
Cash flows from operating activities:    
Net income (loss) $ 29,588 $ (41,268)
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 85,425 101,495
Provision for doubtful accounts (213) (186)
Amortization of deferred financing costs 755 1,872
Settlement of foreign currency forward 0 (3,701)
Loss on disposition or impairment of assets 0 1,845
Deferred income taxes 1,962 (9,145)
Charge for stock based compensation 25,409 27,026
Effect of credit facility issuance and refinancing costs 2,615 32,275
Change in assets and liabilities (net of acquisitions and disposition):    
Accounts receivable 2,180 (24,635)
Inventories (7,509) 16,423
Other current assets (447) 30,196
Other assets 3,398 7,643
Accounts payable (17,682) 11,631
Accrued liabilities (9,283) (55,477)
Other long-term liabilities (3,581) 19,997
Net cash provided by operating activities 112,617 115,991
Cash flows from investing activities:    
Purchases of property and equipment (31,128) (39,750)
Proceeds from the divestiture or sale of assets 0 325
Proceeds from sale of investment 0 4,352
Settlement of foreign currency forward 0 3,701
Payments for acquisitions, net of cash acquired 0 (584,218)
Net cash used in investing activities (31,128) (615,590)
Cash flows from financing activities:    
Repayments of credit facility (76,975) (55,625)
Credit facility issuance and refinancing costs (623) (41,790)
Proceeds from credit facility 277,539 959,708
Extinguishment of debt (277,539) (470,296)
Net proceeds from stock awards 12,719 8,024
Net cash (used in) provided by financing activities (64,879) 400,021
Net increase (decrease) in cash and cash equivalents 16,610 (99,578)
Cash and cash equivalents at beginning of period 204,335 266,631
Cash and cash equivalents at end of period $ 220,945 $ 167,053